Clinical Trial Update: Safety Study of AMG 531 in Japanese Subjects With ITP [Phase 2]

View source ↗

Summary

Phase 2 safety study of romiplostim (AMG 531) in Japanese subjects with immune thrombocytopenia has completed. The study evaluated thrombocytopenia associated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura
• Immune Thrombocytopenia

Drugs mentioned

• Nplate (romiplostim)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Phase 2 | Status: COMPLETED